Intensity Therapeutics, Inc. Common stock (INTS)
Since Aug 14, 2023, Intensity Therapeutics, Inc. Common stock (INTS) has reported earnings 13 times. On average the shares move ±4.25% post-earnings, with a positive reaction 53.8% of the time. Its largest post-earnings gain was +21.77% (Mar 14, 2024) and its largest decline was -6.8% (May 13, 2025). The next earnings report is predicted for 2026-11-10 (approximate).
Earnings reactions
How INTS moved on each past earnings report.
Earnings Impact
Total Earnings
13
Avg Abs. Movement
±4.25%
Positive %
53.8%
Negative %
46.2%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 11, 2026 | ☀ PRE | -0.47% | open_in_new |
| May 07, 2026 | ☽ POST | +0% | open_in_new |
| Mar 27, 2026 | ☽ POST | +0% | open_in_new |
| Nov 06, 2025 | ☽ POST | -5.12% | open_in_new |
Earnings Count
13
Total earnings in dataset
Avg Abs. Movement
±4.25%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260811 | open_in_new SEC.gov |
| 8-K | 20260811 | open_in_new SEC.gov |
| 4 | 20260720 | open_in_new SEC.gov |
| 4 | 20260720 | open_in_new SEC.gov |
| 4 | 20260720 | open_in_new SEC.gov |
| 4 | 20260720 | open_in_new SEC.gov |
| 4 | 20260720 | open_in_new SEC.gov |
| 4 | 20260720 | open_in_new SEC.gov |
| 4 | 20260720 | open_in_new SEC.gov |
| S-8 | 20260708 | open_in_new SEC.gov |
Frequently asked about INTS earnings
When does Intensity Therapeutics, Inc. Common stock report earnings next? expand_more
Intensity Therapeutics, Inc. Common stock (INTS)'s next earnings date is approximate for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does INTS stock move after earnings? expand_more
Over 13 reports, INTS has moved an average of ±4.25% the session after earnings, closing higher 53.8% of the time.
What was INTS's biggest post-earnings move? expand_more
INTS's largest post-earnings gain on record was +21.77% on Mar 14, 2024, and its largest decline was -6.8% on May 13, 2025.
Where can I find Intensity Therapeutics, Inc. Common stock's SEC filings? expand_more
All of Intensity Therapeutics, Inc. Common stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right